EpiCast Report: Migraine Epidemiology Forecast to 2026 [Report Updated: 10082017] Prices from USD $3995
EpiCast Report: Migraine Epidemiology Forecast to 2026
Summary
Migraine is characterized by recurring headaches and throbbing pain on one side of the head accompanied by nausea, vomiting, or increased sensitivity to light or smell. While most migraineurs experience episodic migraines EM, a small percentage suffers from chronic migraine CM. In addition to its debilitating pain, migraines are also associated with more severe cardiovascular and neuropsychological comorbidities. Because migraine is one of the most prevalent types of headache, there is a substantial economic and social burden associated with the condition worldwide, and it is therefore recognized as a highpriority public health problem by the World Health Organization.
In 2016, there were 73,914,635 total prevalent cases of migraine in adults ages 18 years and older in the 7MM. The US had the most cases, while Spain had the fewest. In the 7MM, the number of total prevalent cases of migraine is expected to grow to 74,543,569 by 2026, at an Annual Growth Rate AGR of 0.09%. Since age and sexspecific prevalence was held constant throughout the forecast period, all changes in the total prevalent cases of migraine are the result of demographic changes. GlobalData epidemiologists estimate that 1.61% of total migraine cases in the 7MM in 2016 were CM.
This forecast is supported by countryspecific prevalence studies for each market, most of which are based on nationally representative samples. GlobalData epidemiologists are confident that these sources provide the most accurate and robust data available in each market. Additionally, GlobalData epidemiologists used consistent methodology while creating forecasts for each market. This allows useful and accurate comparisons regarding total prevalent cases of migraine between markets.
Scope
The Migraine EpiCast Report provides an overview of the risk factors and global trends of migraine in the seven major markets 7MM: US, France, Germany, Italy, Spain, UK, and Japan. It includes a 10year epidemiological forecast for the total prevalent cases of migraine segmented by sex and age for ages 18 years and older in these markets. This forecast is further segmented by migraine frequency into episodic migraine EM and chronic migraine CM.
The migraine epidemiology report is written and developed by Masters and PhDlevel epidemiologists.
The EpiCast Report is indepth, high quality, transparent and marketdriven, providing expert analysis of disease trends in the 7MM.
Reasons to buy
The Migraine EpiCast report will allow you to
Develop business strategies by understanding the trends shaping and driving the global migraine market.
Quantify patient populations in the global migraine market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for migraine therapeutics in each of the markets covered.
Identify the percentage of migraine prevalent cases by frequency.
Original Article: EpiCast Report: Migraine Epidemiology Forecast to 2026 [Report Updated: 10082017] Prices from USD $3995
